Groups at the highest risk are left behind in the fight to eliminate hepatitis C at European level, according to the survey Hep-CORE 2018 on the elimination of this virus in Europe, published by the European Association of Patients with Liver Disease (ELPA).
The survey of the European Association of Liver Disease Patients, Hep-CORE and conducted through an assessment of national policies for viral hepatitis C in Europe since 2016, evaluates this year's opportunities for eliminating hepatitis C at national level , within well-defined populations. "25 patient groups from 23 European Mediterranean countries responded to this study. The results show that only 14 of the 25 (56%) countries involved in the study have a national viral hepatitis strategy. Currently, only 12 countries globally are about to eliminate viral hepatitis, and six of these are among the countries studied: Egypt, France, Italy, the Netherlands, Spain and the United Kingdom. The results show that there are systematic loopholes, high-risk populations being ignored if difficult to reach outside existing pathways. Hepatitis at the level of healthcare workers is a major concern, and yet stigma and fear of losing their jobs are some of the barriers that prevent this crucial population from gaining access to testing and care, "reads a press release
ELPA also says that patient group responses show that high-risk populations are subject to disproportionate actions. However, those who are already included in health care services, such as hemodialysis patients and those with haemophilia, as well as donors and transplant recipients, are most likely to be taking care. "The results of the study show that people using injectable drugs (PWID),
» Read the continuation at source: BZI.RO